Navigation Links
CBR Pharma Insights' Latest Report, The New Era of Healthcare Reform - Supporting Revenue Growth through Understanding & Adaptation
Date:7/1/2010

In the latest report from CBR Pharma Insights, the new healthcare reform legislation which was finally passed earlier this year is analyzed to provide pharmaceutical & biotech companies with a comprehensive set of tools to support their current and future business plans.

(PRWEB) July 1, 2010 -- After a hotly contested national debate, healthcare reform legislation was passed in the spring of 2010. The legislation contains many long-term benefits for the pharmaceutical industry, but the industry must continue to play an active role in legislation implementation to ensure those benefits are realized.

Through the new laws, there are both wins and losses for the pharmaceutical industry, such as changes effecting Medicare/Medicaid, health insurance coverage expansion & protection, taxation and patent protection. However, on balance most changes hold significant long-term potential for the industry.

While pharma played a very important role in promoting health reform during the debate over change, the work is not done. Many of the greatest potential benefits of the legislation – including extending healthcare coverage to 32 million more Americans – will come down the road. Thus, it is crucial for pharma to remain involved with the healthcare reform roll-out going forward.

Use CBR Pharma Insights' new report, "The New Era of Healthcare Reform - Supporting Revenue Growth through Understanding and Adaptation" to:

 
  • Analyze the possible impact that the new healthcare reform legislation could have on your company’s future growth potential
  • Assess the role pharmaceutical companies need to play to best ensure that all potential benefits are actually realized
  • Learn the pitfalls for the pharmaceutical industry to avoid as the new legislation is rolled-out
  • Identify the opportunities for growth in the new reform environment
  • Understand the ways the new healthcare reform bill can help change how healthcare is delivered in the United States

For more information about this report, please go to: http://www.cbrpharmainsights.com/inner/StrategicVisionProducts/CBRSV014pg.html

About CBR Pharma Insights - CBR Pharma Insights is a strategic market research firm whose mission is to empower companies to make the best business decisions possible through providing them with quality, innovative market research solutions. www.cbrpharmainsights.com

###

Read the full story at http://www.prweb.com/releases/2010/07HealthcareReform/prweb4211594.htm.


'/>"/>
Source: PRWeb
Copyright©2010 Vocus, Inc.
All rights reserved  

Related biology technology :

1. Pharmalink AB Closes Deal With Grifols SA for the Acquisition of the Xepol(R) Programme for the Treatment of Post-Polio Syndrome
2. Therapure Biopharma Inc. Signs Biomanufacturing Contract with Diamedica Incorporated
3. Dragon Pharma announces date of special meeting
4. Caliper Owners Group Meeting Showcases Critical Role of Biopharma and Academic Researchers for Improving Healthcare and Quality of Life
5. Progenika Biopharma Grants Grifols World-Wide Distribution Rights for the BLOODCHIP® Genotyping Test for Blood Donors
6. Angiotech Pharmaceuticals Announces Conference Call and Webcast
7. Three Top 20 Pharmaceutical Companies Select iCardiac as Preferred Vendor
8. Sosei to Acquire Activus Pharma
9. OncoGenex Pharmaceuticals Announces Initiation of a Phase 3 Trial in Men with Metastatic Prostate Cancer
10. Therapure Biopharma Inc. Signs Biomanufacturing Contract with ProChon Biotech Ltd.
11. Melissa Kemp, Ph.D., Wins the Council for Systems Biology in Boston (CSB2) Award Sponsored by Merrimack Pharmaceuticals, Inc.
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
CBR Pharma Insights' Latest Report, The New Era of Healthcare Reform - Supporting Revenue Growth through Understanding & Adaptation 
(Date:5/26/2016)... , May 26, 2016 Despite the ... value in this space. Today,s pre-market research on ActiveWallSt.com directs ... Health Inc. (NASDAQ: RDUS ), Cerus Corp. (NASDAQ: ... ARWR ), and Five Prime Therapeutics Inc. (NASDAQ: ... briefings at: http://www.activewallst.com/ On ...
(Date:5/26/2016)... San Diego, CA (PRWEB) , ... May 26, ... ... assay development and manufacturing company, today announced several positive developments that position the ... As a result of the transaction, Craig F. Kinghorn has been appointed ...
(Date:5/25/2016)... ... May 25, 2016 , ... Lajollacooks4u has become a rising ... been rated one of its top attractions. Fortune 500 companies, such as Illumina, ... a unique and intimate team-building experience. , Each event kicks off with an olive ...
(Date:5/25/2016)... ... May 25, 2016 , ... The Ankle Plating ... options designed to address fractures of the distal tibia and fibula. This system ... Ankle Plating System 3 is composed of seven plate families that span the ...
Breaking Biology Technology:
(Date:3/15/2016)... -- Yissum Research Development Company of the Hebrew ... Hebrew University, announced today the formation of Neteera ... human biological indicators. Neteera Technologies has completed its first ... ... emissions from sweat ducts, enables reliable and speedy biometric ...
(Date:3/14/2016)... , Allemagne, March 14, 2016 ... http://www.apimages.com ) - --> - Renvoi : ... - --> --> ... solutions biométriques, fournit de nouveaux lecteurs d,empreintes digitales ... LF10 de DERMALOG sera utilisé pour produire des ...
(Date:3/11/2016)... India , March 11, 2016 ... a new market research report "Image Recognition Market by ... Application (Marketing and Advertising), by Deployment Type (On-Premises and ... Forecast To 2022", published by MarketsandMarkets, the global market ... 2015 to USD 29.98 Billion by 2020, at a ...
Breaking Biology News(10 mins):